President Donald Trump met with pharma executives in a meeting that had once been billed as a scolding over high prices. But now that the industry is needed to help develop a vaccine for the emerging pandemic, Trump has taken a more congenial tone with the executives. Meanwhile, Stat takes a closer look at where everyone stands on developing coronavirus-related drugs and vaccines.
from Kaiser Health News https://ift.tt/2PYlxtZ
March 03, 2020
Rose
Health News, Kaiser Health News
No comments
Related Posts:
First Edition: June 25, 2018Today's early morning highlights from the major news organizations. from Kaiser Health News https://ift.tt/2IoqwgP … Read More
Rx: Zucchini, Brown Rice, Turkey Soup. Medicaid Plan Offers Food As Medicine.… Read More
Law Aims To Help Medicare Tackle Expensive Problem Of Costs From Chronic IllnessesHalf of Medicare patients are treated for five or more chronic conditions each year, and they account for three-fourths of Medicare spending. The law, which has bipartisan support, allows Medicare to focus on the social facto… Read More
Viewpoints: Small Businesses Make Huge Gains On Health Care; Puerto Rico Deserves A Better ResponseOpinion writers look at changes impacting the health law and other health issues. from Kaiser Health News https://ift.tt/2tkKF2G … Read More
Fearing Deportation, Immigrant Parents Are Opting Out Of Health Benefits For Kids… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment